AR006539A1 - Derivados de diarilmetilidenfurano, procedimiento para su preparacion y composicion farmaceutica que contiene a dichos derivados. - Google Patents

Derivados de diarilmetilidenfurano, procedimiento para su preparacion y composicion farmaceutica que contiene a dichos derivados.

Info

Publication number
AR006539A1
AR006539A1 ARP970101359A ARP970101359A AR006539A1 AR 006539 A1 AR006539 A1 AR 006539A1 AR P970101359 A ARP970101359 A AR P970101359A AR P970101359 A ARP970101359 A AR P970101359A AR 006539 A1 AR006539 A1 AR 006539A1
Authority
AR
Argentina
Prior art keywords
derivatives
methylidenfuran
diaryl
procedure
preparation
Prior art date
Application number
ARP970101359A
Other languages
English (en)
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Publication of AR006539A1 publication Critical patent/AR006539A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se refiere a los derivados del diarilmetilidenfurano de la fórmula (I) y en la cual las cadenas cerradas A y B son, de manera independiente: unradical fenilo; un radical naftilo; un radical que deriva de un heterociclo que contiene entre 5 y 6m iembros y posee entre 1 y 4 heteroátomos; un radicalque deriva de una cadena de hidrocarburo saturado que posee entre 3 y 7 átomos de carbono.
ARP970101359A 1996-04-04 1997-04-04 Derivados de diarilmetilidenfurano, procedimiento para su preparacion y composicion farmaceutica que contiene a dichos derivados. AR006539A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604236A FR2747123B1 (fr) 1996-04-04 1996-04-04 Nouveaux derives diarylmethylidene tetrahydrofurane, leurs procedes de preparation, et leurs utilisations en therapeutique
FR9607922A FR2747124B1 (fr) 1996-04-04 1996-06-26 Nouveaux derives diarylmethylidene furaniques, leurs procedes de preparation et leurs utilisations en therapeutique

Publications (1)

Publication Number Publication Date
AR006539A1 true AR006539A1 (es) 1999-09-08

Family

ID=9490907

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101359A AR006539A1 (es) 1996-04-04 1997-04-04 Derivados de diarilmetilidenfurano, procedimiento para su preparacion y composicion farmaceutica que contiene a dichos derivados.

Country Status (28)

Country Link
EP (1) EP0891345B1 (es)
JP (1) JP2000508638A (es)
KR (1) KR20000005146A (es)
CN (1) CN1215396A (es)
AR (1) AR006539A1 (es)
AT (1) ATE204268T1 (es)
AU (1) AU717146B2 (es)
BG (1) BG62808B1 (es)
BR (1) BR9708510A (es)
CA (1) CA2248949A1 (es)
CZ (1) CZ318898A3 (es)
DE (1) DE69706157T2 (es)
DK (1) DK0891345T3 (es)
EE (1) EE03687B1 (es)
ES (1) ES2162678T3 (es)
FR (2) FR2747123B1 (es)
GE (1) GEP20032924B (es)
IL (1) IL126105A (es)
NO (1) NO984624L (es)
NZ (1) NZ331672A (es)
PL (1) PL329213A1 (es)
PT (1) PT891345E (es)
RU (1) RU2189979C2 (es)
SI (1) SI0891345T1 (es)
SK (1) SK283292B6 (es)
TW (1) TW353660B (es)
WO (1) WO1997037984A1 (es)
ZA (1) ZA972894B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180651B1 (en) * 1996-04-04 2001-01-30 Bristol-Myers Squibb Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics
WO1998043966A1 (en) * 1997-04-02 1998-10-08 Merck Frosst Canada & Co. Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors
FR2775477B1 (fr) * 1998-02-27 2000-05-19 Union Pharma Scient Appl Nouveaux derives diarylmethylene heterocycliques, leurs procedes de preparation et leurs utilisations en therapeutique
CN1106392C (zh) * 2000-10-24 2003-04-23 中国科学院上海有机化学研究所 一种β位不含取代基的丁烯酸内酯及其合成的方法
CN102579427A (zh) * 2002-11-05 2012-07-18 马格纳化学国际实验室公司 合成的内酯制剂及其使用方法
WO2004087644A1 (en) * 2003-03-31 2004-10-14 Council Of Scientific And Industrial Research Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof
AU2004237439B2 (en) 2003-05-07 2009-09-10 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
US8779168B2 (en) * 2010-12-16 2014-07-15 Transitions Optical, Inc. Lactone compounds and materials made therefrom
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69406903T2 (de) * 1993-01-15 1998-04-09 Searle & Co 3,4-diarylthiophene und analoga davon, sowie deren verwendung als entzündungshemmende mittel
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge

Also Published As

Publication number Publication date
NO984624D0 (no) 1998-10-02
BR9708510A (pt) 1999-08-03
FR2747124A1 (fr) 1997-10-10
KR20000005146A (ko) 2000-01-25
AU2393397A (en) 1997-10-29
SI0891345T1 (en) 2002-02-28
CA2248949A1 (fr) 1997-10-16
CN1215396A (zh) 1999-04-28
ZA972894B (en) 1997-11-04
EP0891345A1 (fr) 1999-01-20
TW353660B (en) 1999-03-01
BG102771A (en) 1999-06-30
EE03687B1 (et) 2002-04-15
NO984624L (no) 1998-11-30
AU717146B2 (en) 2000-03-16
IL126105A (en) 2001-08-26
IL126105A0 (en) 1999-05-09
EP0891345B1 (fr) 2001-08-16
NZ331672A (en) 2000-02-28
GEP20032924B (en) 2003-03-25
JP2000508638A (ja) 2000-07-11
PL329213A1 (en) 1999-03-15
DE69706157T2 (de) 2002-04-11
DE69706157D1 (de) 2001-09-20
SK137598A3 (en) 1999-02-11
FR2747123B1 (fr) 1998-06-26
WO1997037984A1 (fr) 1997-10-16
DK0891345T3 (da) 2001-12-03
EE9800333A (et) 1999-04-15
FR2747123A1 (fr) 1997-10-10
BG62808B1 (bg) 2000-08-31
CZ318898A3 (cs) 1999-01-13
SK283292B6 (sk) 2003-05-02
FR2747124B1 (fr) 1998-06-26
ATE204268T1 (de) 2001-09-15
PT891345E (pt) 2002-02-28
ES2162678T3 (es) 2002-01-01
RU2189979C2 (ru) 2002-09-27

Similar Documents

Publication Publication Date Title
ECSP003682A (es) Compuestos para el tratamiento de la isquemia
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2175443T3 (es) Compuestos de naptopirano y articulos que los contienen.
DK0527801T3 (da) Thiophensulfonamider, der er anvendelige som carboanhydraseinhibitorer
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
ES2124062T3 (es) Derivados de nucleosido fosforotioato, sintesis y uso de los mismos.
CO4910163A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
ES2102093T3 (es) Procedimiento para la preparacion de inulina de cadena larga.
ES2044849T3 (es) Un procedimiento para preparar un glicosido de flavona.
ES2192031T3 (es) Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.
AR006539A1 (es) Derivados de diarilmetilidenfurano, procedimiento para su preparacion y composicion farmaceutica que contiene a dichos derivados.
ES2171715T3 (es) Procedimiento de hidroisomerizacion selectiva de parafinas largas lineales y/o poco ramificadas con un catalizador a base de tamiz molecular.
ES2117474T3 (es) Derivados n-sustituidos del 4-hidroxiindol y composiciones de tinte de fibras queratinicas que los contienen.
ES2192680T3 (es) Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
AR007280A1 (es) Derivados de sustancia activa, composicion y procedimiento para el tratamiento del cabello
ES2163896T3 (es) Composiciones para aumentar la concentracion y/o motilidad de los espermatozoos en humanos.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK0842165T3 (da) Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler
AR025951A1 (es) Derivados de 4-hicroxibifenil hidrazidas y métodos para preparar los derivados.
ES2070416T3 (es) Moluscicidas.
ES2117664T3 (es) Carboximetilmanoglucanos y derivados de los mismos.
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
ES2175297T3 (es) Nuevos derivados de la melatonina que presentan una actividad anti-radicales libres y composiciones que comprenden los mismos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal